Transarterial and transvenous access for neurointerventional surgery: report of the SNIS Standards and Guidelines Committee
- PMID: 31818970
- DOI: 10.1136/neurintsurg-2019-015573
Transarterial and transvenous access for neurointerventional surgery: report of the SNIS Standards and Guidelines Committee
Abstract
The purpose of this publication is to provide a comprehensive review on the techniques and tools used for vascular access in neurointerventional procedures. Using published literature, we reviewed data on access methods, sites, tools, and techniques for neurointerventions. Recommendations are provided based on quality of data/levels of evidence and, where appropriate, expert consensus. While tools and techniques continue to be developed, current literature and experience supports certain principles regarding vascular access for neurointerventional procedures.
Keywords: Angiography; Standards; Stroke.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: JFF is an equity interest holder for Cerelux, and for Fawkes Biotechnology, LLC, and a consultant for Stream Biomedical, Penumbra, and Medtronic Neurovascular. He has research support from the University of Kentucky and the American Heart Association. RMS receives research support from NREF, Joe Niekro Foundation, Brain Aneurysm Foundation, Bee Foundation, NIH, Miami Clinical and Translational Science Institute, National Center for Advancing Translational Sciences and the National Institute on Minority Health and Health Disparities. He is a consultant for Penumbra, Abbott, Medtronic, and Cerenovus. GD is a consultant for Medtronic, Microvention, Penumbra, and Cerenovus. He is a shareholder in InNeuroCo, RIST, Cleerly, and eLum. BS has equity in RIST Neurovascular. Dr Kan is a consultant for Stryker and Medtronic Neurovascular. YK is a consultant for Penumbra and for Medtronic Neurovascular. PMM is a consultant for Stryker, Medtronic, Penumbra, and Siemens. ASA is a consultant for Balt, Johnson and Johnson, Leica, Medtronic, Microvention, Penumbra, Scientia, Siemens, and Stryker. He has research support from Cerenovus, Microvention, Penumbra and Siemens. He is a shareholder in Bendit, Cerebrotech, Endostream, Magneto, Marblehead, Neurogami, Serenity, Synchron, Triad Medical, and Vascular Simulations. BB is a consultant for Penumbra, Medtronic, Stryker, Metactive, and 880 Medical, He has stock in Penumbra, and stock options in Viz.ai. He has ownership interest in Route 92 and Marblehead. MC is a consultant for Medtronic, Stryker, Genentech, Imperative Health, Microvention, and Cerenovus. RDL is a consultant for Imperative Care, Siemens, and Penumbra, and owns equity in Q’Apel. He is also on the scientific advisory boards for Cerenovus and receives research support from Asahi and Medtronic. KF is a consultant for Cerebrotech. DF is a consultant for Genentech, Penumbra, and Stryker. He has stock ownership in Penumbra. SH has a Royalty Agreement with Penumbra. He Contracts for Core Imaging Lab for Stryker and MicroVention. He has a research contract with Siemens. He is on Data Safety and Monitoring Boards for DAWN, ARISE2, and PHIL trials. He has grant support through NCI and NIBIB. MSH is a consultant for Cerenovus. MVJ is a speaker for Medtronic. RPK is a consultant for Medtronic, Cerenovus, and Microvention. WJM is a consultant for Q’Apel, Rebound Therapeutics, Viseon TSP, Medtronic, Penumbra, and Stream Biomedical. He is an investor in Cerebrotech, Endostream, Viseon, and Rebound Therapeutics.JMM is a consultant for Stryker and Penumbra. MM is a consultant for Canon Medical and Medtronic. He has financial interest in Serenity Medical and VICIS. JM receives research support from Stryker, Penumbra, Medtronic, and Microvention. He is a consultant for Imperative Care, Cerebrotech, Viseon, Endostream, Rebound Therapeutics, and Vastrax. He is an investor/shareholder in BlinkTBI, Serenity, NTI, Neurvana, and Cardinal Consulting. GLP is a consultant for Sequent and Microvention-Terumo. He is on the Data Safety and Monitoring Board for Web-IT Study (Cerenovus) and for the Pulserider NAPA trial. ATR is a consultant for Stryker Neurovascular and Microventions. He is on an Advisory Board for Cerenovus, and is a stockholder in NTI. CS has equity in Neurotechnology Investors. AHS receives research support from NIH. He has financial interests in Amnis Therapeutics, BlinkTBI, Buffalo Technology Partners, Cardinal Consultants, Cerebrotech Medical Systems, Cognition Medical, Endostream Medical, Imperative Care, International Medical Distribution Partners, Neurovascular Diagnostics, Q’Apel Medical, Rebound Therapeutics, Rist Neurovascular, Serenity Medical, Silk Road Medical, Spinnaker Medical, StimMed, Synchron, Three Rivers Medical, and Viseon Spine. He is a consultant for Amnis Therapeutics, Boston Scientific, Canon Medical Systems, Cerebrotech Medical Systems, Cerenovus, Corindus, Endostream Medical, Guidepoint Global Consulting, Imperative Care, Integra, Medtronic, MicroVention, Northwest University, Penumbra, Q’Apel Medical, Silk Road Medical, StimMed, Stryker, Three Rivers Medical, VasSol, and WL Gore and Associates. Dr Toth is a consultant for Dynamed EBSCO.
Similar articles
-
Current endovascular strategies for posterior circulation large vessel occlusion stroke: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee.J Neurointerv Surg. 2019 Oct;11(10):1055-1062. doi: 10.1136/neurintsurg-2019-014873. Epub 2019 May 18. J Neurointerv Surg. 2019. PMID: 31103994 Review.
-
Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery.J Neurointerv Surg. 2017 Mar;9(3):316-323. doi: 10.1136/neurintsurg-2015-011984. Epub 2015 Aug 31. J Neurointerv Surg. 2017. PMID: 26323793
-
Society of NeuroInterventional Surgery Standards of Practice: general considerations.J Neurointerv Surg. 2012 Jan 1;4(1):11-5. doi: 10.1136/neurintsurg-2011-010180. J Neurointerv Surg. 2012. PMID: 22166819 Review.
-
Endovascular therapy of acute ischemic stroke: report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery.J Neurointerv Surg. 2012 Mar;4(2):87-93. doi: 10.1136/neurintsurg-2011-010243. Epub 2012 Jan 24. J Neurointerv Surg. 2012. PMID: 22278933 Review.
-
Social media usage for neurointerventionalists: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee.J Neurointerv Surg. 2021 Jul;13(7):674-678. doi: 10.1136/neurintsurg-2021-017278. Epub 2021 Mar 15. J Neurointerv Surg. 2021. PMID: 33722972 Review.
Cited by
-
Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Comparison of Transradial Versus Transfemoral Cerebral Angiography.Cureus. 2020 Oct 12;12(10):e10919. doi: 10.7759/cureus.10919. Cureus. 2020. PMID: 33194486 Free PMC article. Review.
-
Transradial artery access for carotid artery stenting: A pooled analysis.Neuroradiol J. 2024 Oct;37(5):546-555. doi: 10.1177/19714009231224410. Epub 2024 Jan 3. Neuroradiol J. 2024. PMID: 38171509
-
Combined Transradial and Upper Extremity Transvenous Accesses in the Treatment of Carotid-Cavernous Fistulae: Two Case Reports and a Literature Review.Cureus. 2022 Apr 13;14(4):e24094. doi: 10.7759/cureus.24094. eCollection 2022 Apr. Cureus. 2022. PMID: 35573517 Free PMC article.
-
Anatomic Snuffbox (Distal Radial Artery) and Radial Artery Access for Treatment of Intracranial Aneurysms with FDA-Approved Flow Diverters.AJNR Am J Neuroradiol. 2021 Mar;42(3):487-492. doi: 10.3174/ajnr.A6953. Epub 2021 Jan 14. AJNR Am J Neuroradiol. 2021. PMID: 33446501 Free PMC article.
-
CTA-Based Patient-Tailored Femoral or Radial Frontline Access Reduces the Rate of Catheterization Failure in Chronic Subdural Hematoma Embolization.AJNR Am J Neuroradiol. 2021 Mar;42(3):495-500. doi: 10.3174/ajnr.A6951. Epub 2021 Feb 4. AJNR Am J Neuroradiol. 2021. PMID: 33541902 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical